Sunshine Biopharma (SBFM) Leases: 2019-2025
Historic Leases for Sunshine Biopharma (SBFM) over the last 3 years, with Sep 2025 value amounting to $820,489.
- Sunshine Biopharma's Leases rose 51.53% to $820,489 in Q3 2025 from the same period last year, while for Sep 2025 it was $820,489, marking a year-over-year increase of 51.53%. This contributed to the annual value of $936,037 for FY2024, which is 44.72% up from last year.
- Per Sunshine Biopharma's latest filing, its Leases stood at $820,489 for Q3 2025, which was down 8.10% from $892,817 recorded in Q2 2025.
- In the past 5 years, Sunshine Biopharma's Leases ranged from a high of $936,037 in Q4 2024 and a low of $541,468 during Q3 2024.
- In the last 3 years, Sunshine Biopharma's Leases had a median value of $711,059 in 2023 and averaged $727,830.
- In the last 5 years, Sunshine Biopharma's Leases declined by 20.69% in 2024 and then skyrocketed by 58.32% in 2025.
- Quarterly analysis of 4 years shows Sunshine Biopharma's Leases stood at $760,409 in 2022, then dropped by 14.94% to $646,779 in 2023, then soared by 44.72% to $936,037 in 2024, then surged by 51.53% to $820,489 in 2025.
- Its Leases was $820,489 in Q3 2025, compared to $892,817 in Q2 2025 and $900,890 in Q1 2025.